Viruses and cancer risks: Outgrowth of Epstein-Barr virus-positive Burkitt's lymphoma in the immune host
- 18 Downloads
This work examines ways in which Epstein-Barr (EB) virus-positive Burkitt's lymphoma (BL) cells achieve outgrowthin vivo in the face of prevailing EB virus-specific cytotoxic T-cell surveillance. Earlier work has shown that some, but not all, BL cell linesin vitro are insensitive to virus-specific T-cell cytolysis and the present study identifies two mechanisms whereby the tumour cells might evade detection. First, BL-cell lines which stably retain the original tumour cell phenotype on serial passagein vitro show very low expression of two cell adhesion-related molecules, LFA-1 and ICAM 1, and are negative for a third such molecule, LFA-3; these molecules are thought to play a crucial role in the non antigen-dependent phase of effector: target cell conjugation which precedes antigen-specific recognition and target cell lysis. Secondly, those same BL cell lines display an unusually restricted pattern of EB virus latent gene expression with at least two potentially important target proteins for the T-cell response, namely EBNA 2 and LMP, not detectably expressed.
Key wordsEB virus Burkitt's lymphoma Cell phenotype Viral proteins T-cell recognition
Unable to display preview. Download preview PDF.
- 5.Dambaugh T, Hennessy K, Fennewald S, Kieff E: The virus genome and its expression in latent infection, in Epstein M A, Achong B G (eds):The Epstein-Barr Virus: Recent Advances, pp. 13–45. London, William Heinemann (1986).Google Scholar
- 9.Lenoir G M: Role of the virus, chromosomal translocations and cellular oncogenes in the aetiology of Burkitt's lymphoma, in Epstein M A, Achong B G (eds),The Epstein-Barr Virus: Recent Advances, pp. 183–205. London, William Heinemann (1986).Google Scholar
- 10.Cleary M L, Dorfman R F, Sklar J: Failure in immunological control of the virus infection: post-transplant lymphomas, in Epstein M A, Achong B G (eds):The Epstein-Barr Virus: Recent Advances, pp. 163–181. London, William Heinemann (1986).Google Scholar
- 12.Rooney C M, Rickinson A B, Moss D J, Lenoir G M, Epstein M A: Cell-mediated immunosurveillance mechanisms and the pathogenesis of Burkitt's lymphoma, in Lenoir G M, O'Conor G T O, Olweny C L M (eds):Burkitt's Lymphoma: A Human Cancer Model, vol. 60, pp. 249–264, Lyon, IARC Scientific Publications (1985).Google Scholar
- 13.Lenoir G M, Vuillaume M, Bonnardel C: Use of lymphomatous and lymphoblastoid cell lines in the study of Burkitt's lymphoma, in, Lenoir G M, O'Conor G, Olweny C L M (eds):Burkitt Lymphoma: A Human Cancer Model, vol. 60, pp. 309–318. Lyon, IARC Scientific Publications (1985).Google Scholar
- 14.Rooney C M, Gregory C D, Rowe M, Finerty S, Edwards C, Rupani H, Rickinson A B: Endemic Burkitt's lymphoma: phenotypic analysis of Burkitt's lymphoma biopsy cells and of the derived tumour cell lines.J Natn Cancer Inst 77, 681 (1986).Google Scholar
- 29.Rooney C M, Rickinson A B, Moss D J, Lenoir G M, Epstein M A: Paired Epstein-Barr virus-carrying lymphoma and lymphoblastoid cell lines from Burkitt's lymphoma patients: comparative sensitivity to non-specific and to allo-specific cytotoxic responsesin vitro.Int J Cancer 34, 339 (1984).PubMedCrossRefGoogle Scholar